Your browser doesn't support javascript.
loading
Conserved regulatory motifs in the juxtamembrane domain and kinase N-lobe revealed through deep mutational scanning of the MET receptor tyrosine kinase domain.
Estevam, Gabriella O; Linossi, Edmond M; Macdonald, Christian B; Espinoza, Carla A; Michaud, Jennifer M; Coyote-Maestas, Willow; Collisson, Eric A; Jura, Natalia; Fraser, James S.
Afiliação
  • Estevam GO; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States.
  • Linossi EM; Tetrad Graduate Program, University of California San Francisco, San Francisco, United States.
  • Macdonald CB; Cardiovascular Research Institute, University of California San Francisco, San Francisco, United States.
  • Espinoza CA; Department of Cellular and Molecular Pharmacology, University of California San Francisco, United States.
  • Michaud JM; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States.
  • Coyote-Maestas W; Tetrad Graduate Program, University of California San Francisco, San Francisco, United States.
  • Collisson EA; Cardiovascular Research Institute, University of California San Francisco, San Francisco, United States.
  • Jura N; Department of Cellular and Molecular Pharmacology, University of California San Francisco, United States.
  • Fraser JS; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States.
bioRxiv ; 2023 Aug 03.
Article em En | MEDLINE | ID: mdl-37577651
ABSTRACT
MET is a receptor tyrosine kinase (RTK) responsible for initiating signaling pathways involved in development and wound repair. MET activation relies on ligand binding to the extracellular receptor, which prompts dimerization, intracellular phosphorylation, and recruitment of associated signaling proteins. Mutations, which are predominantly observed clinically in the intracellular juxtamembrane and kinase domains, can disrupt typical MET regulatory mechanisms. Understanding how juxtamembrane variants, such as exon 14 skipping (METΔEx14), and rare kinase domain mutations can increase signaling, often leading to cancer, remains a challenge. Here, we perform a parallel deep mutational scan (DMS) of MET intracellular kinase domain in two fusion protein backgrounds wild type and METΔEx14. Our comparative approach has revealed a critical hydrophobic interaction between a juxtamembrane segment and the kinase αC helix, pointing to differences in regulatory mechanisms between MET and other RTKs. Additionally, we have uncovered a ß5 motif that acts as a structural pivot for kinase domain activation in MET and other TAM family of kinases. We also describe a number of previously unknown activating mutations, aiding the effort to annotate driver, passenger, and drug resistance mutations in the MET kinase domain.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: BioRxiv Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos